Penedones A - Search Results

1

[Pharmacovigilance in Portugal: Activity of the Central Pharmacovigilance Unit].

Batel-Marques F, Mendes D, Alves C, Penedones A, Dias P, Martins A, Santiago LM, Fontes-Ribeiro C, Caramona M, Macedo T. Batel-Marques F, et al. Among authors: penedones a. Acta Med Port. 2015 Mar-Apr;28(2):222-32. Epub 2015 May 29. Acta Med Port. 2015. PMID: 26061513 Free article. Portuguese.

2

Safety monitoring of ophthalmic biologics: a systematic review of pre- and postmarketing safety data.

Penedones A, Mendes D, Alves C, Batel Marques F. Penedones A, et al. J Ocul Pharmacol Ther. 2014 Nov;30(9):729-51. doi: 10.1089/jop.2013.0206. Epub 2014 Jul 29. J Ocul Pharmacol Ther. 2014. PMID: 25073069 Review.

3

Drug-induced ocular adverse reactions: review of the safety alerts issued during the last decade.

Penedones A, Mendes D, Alves C, Marques FB. Penedones A, et al. J Ocul Pharmacol Ther. 2015 Jun;31(5):258-68. doi: 10.1089/jop.2014.0165. Epub 2015 Apr 14. J Ocul Pharmacol Ther. 2015. PMID: 25871404 Review.

4

The Role of Disproportionality Analysis of Pharmacovigilance Databases in Safety Regulatory Actions: a Systematic Review.

Dias P, Penedones A, Alves C, Ribeiro CF, Marques FB. Dias P, et al. Among authors: penedones a. Curr Drug Saf. 2015;10(3):234-50. doi: 10.2174/1574886310666150729112903. Curr Drug Saf. 2015. PMID: 26219291 Review.

5

A systematic review and meta-analysis of the association between systemic fluoroquinolones and retinal detachment.

Alves C, Penedones A, Mendes D, Batel Marques F. Alves C, et al. Among authors: penedones a. Acta Ophthalmol. 2016 Aug;94(5):e251-9. doi: 10.1111/aos.12931. Epub 2016 Feb 5. Acta Ophthalmol. 2016. PMID: 26846201 Free article. Review.

6

Risk of Ophthalmic Adverse Effects in Patients Treated with MEK Inhibitors: A Systematic Review and Meta-Analysis.

Alves C, Ribeiro I, Penedones A, Mendes D, Batel Marques F. Alves C, et al. Among authors: penedones a. Ophthalmic Res. 2017;57(1):60-69. doi: 10.1159/000446845. Epub 2016 Jul 13. Ophthalmic Res. 2017. PMID: 27404571 Review.

7

A systematic review of observational studies evaluating costs of adverse drug reactions.

Batel Marques F, Penedones A, Mendes D, Alves C. Batel Marques F, et al. Among authors: penedones a. Clinicoecon Outcomes Res. 2016 Aug 24;8:413-26. doi: 10.2147/CEOR.S115689. eCollection 2016. Clinicoecon Outcomes Res. 2016. PMID: 27601925 Free PMC article. Review.

8

Outcomes From the First 6 Years of Operation of the Central Portugal Pharmacovigilance Unit.

Batel-Marques F, Penedones A, Mendes D, Alves C. Batel-Marques F, et al. Among authors: penedones a. J Patient Saf. 2020 Sep;16(3):e136-e142. doi: 10.1097/PTS.0000000000000273. J Patient Saf. 2020. PMID: 27997457

9

Methodologic Assessment of the Systematic Reviews of Ophthalmic Adverse Drug Reactions Published in Ophthalmology Journals: A Systematic Review.

Penedones A, Batel Marques F. Penedones A, et al. Ophthalmic Res. 2018;60(2):55-68. doi: 10.1159/000489932. Epub 2018 Jul 5. Ophthalmic Res. 2018. PMID: 29975961 Review.

10

Intensive safety monitoring program of antineoplastic medicines: A pilot study in a Portuguese oncology hospital.

Mendes D, Rigueiro G, Silva RS, Penedones A, Alves C, Sousa G, Batel-Marques F. Mendes D, et al. Among authors: penedones a. J Oncol Pharm Pract. 2020 Jan;26(1):133-140. doi: 10.1177/1078155219849277. Epub 2019 May 22. J Oncol Pharm Pract. 2020. PMID: 31117914

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

27 results

Search Page

Filters